protochordate to higher vertebrates and using a broad range of embryology and molecular biology approaches. Rodent NC stem cell and/or precursor populations have been isolated from both fetal and adult tissues such as gut and sciatic nerve, and several studies have attempted the isolation of NC cells from mouse ESCs using transgenic approaches or antibodybased cell selection [24] [25] [26] [27] . Such studies have shed light on the evolutionary history of NC development and defined conserved genetic regulatory systems 28, 29 . However, despite these extensive studies across many species 25 , our understanding of early human NC development has remained limited owing to the lack of an appropriate experimental system.
Derivation and isolation of NC cells from hESCs
Here we present protocols for the induction of NC cells derived from hESCs and for the isolation and further expansion/differentiation of hESC-derived NC cells (Figs. 3 and 4) . Similar approaches based on enrichment of hESC-NC by flow cytometry were published by two independent laboratories after our initial report, although slightly different surface markers or antibodies were used in those studies 30, 31 . Currently, it is unclear whether these alternative protocols offer any specific advantages as compared with our original protocol.
It is very difficult to obtain primary human embryonic or fetal NC cells as stage-matched control tissue. Therefore, it is critical to carefully validate NC identity of the differentiated cells to rule out alternative cell fates with potentially overlapping marker expression such as neuroblast-and cranial placode-derived cells. Other than hESCs, our protocols are also applicable to hiPSC lines derived from somatic cells such as normal fibroblasts, as well as fibroblasts 9, 32 derived from patients with NC-related genetic disorders such as familial dysautonomia. We have recently shown the use of familial dysautonomia-induced pluripotent stem cells for modeling the pathogenesis and treatment of this rare genetic disorder 33 . The application of hiPSC technology in combination with NC differentiation protocol presented here should serve as a valuable tool for probing the pathogenesis and for validating candidate drugs 34 in many other NC-related disorders. Finally, our protocols can also serve as the basis for efforts aimed at further refining NC-directed differentiation protocols. Some of the key remaining issues are (1) precise manipulation of anterior-posterior identity of hESCderived NC precursors (cranial versus trunk versus sacral NC lineages); (2) molecular control of cell fate decision along sensory versus autonomic neuron lineages and further sublineages (e.g., nociceptive neurons); (3) characterizing the lineage and stem cell potential of early versus late emerging NC populations from hESCs; (4) optimizing strategies for directed differentiation of other NC lineages, such as melanocytes, sympathoadrenal lineage, cardiac NC and enteric neurons not yet isolated using our protocol; (5) defining the lineage relationship of NC-associated mesenchymal lineages 35 ; and (6) fully characterizing and comparing the lineage potential of NC precursors derived from NSB protocol 9 versus the MS5 6 and other alternative NC protocols. 
MaterIals

REAGENTS
Mitotically inactivated primary mouse fetal fibroblasts (PMEF, Chemicon, PMEF-CF or CF-1 MEF, GlobalStem) hESCs and hiPSCs ! cautIon Appropriate consent procedures and administrative regulations must be followed for work involving hESCs and hiPSCs. Please consult the institution to assure adherence with national and institutional guidelines and regulations. 
REAGENT SETUP  crItIcal Sterilize all media using 0.22 µm filtration. For mesenchymal differentiation Prepare the following stock solutions: 0.5 M IBMX in DMSO (1,000× stock), 10 mM dexamethasone solution in ethanol (1,000× stock) and 1 M β-glycerol phosphate solution in distilled water (100× stock). Store stock solutions at 4 °C. Use within 1 month. hESC medium for maintenance (1 liter, use within 2 weeks) Combine DMEM/F12 (800 ml), 200 ml of KSR, 5 ml of L-Glutamine, 5 ml of Pen/Strep, 10 ml of 10 mM MEM minimum nonessential amino acids solution, 1,000 µl of β-mercaptoethanol and FGF-2 (final concentration is 4 ng ml − 1 ). KSR medium for hESC differentiation (1 liter, use within 2 weeks) Knockout DMEM (820 ml), 150 ml of KSR, 10 ml of L-Glutamine, 10 ml of Pen/Strep, 10 ml of 10 mM MEM and 1 ml of β-mercaptoethanol. N2 medium for hESC differentiation (1 liter, use within 2 weeks) Dist. H 2 O (985 ml) with DMEM/F12 powder, 1.55 g Glucose, 2.00 g NaHCO 3 , 25 mg Insulin, 0.1 g apotransferrin, 30 nM sodium selenite, 100 µM putrescine and 20 nM progesterone. DMEM with 10% FBS for preparing PMEF (1 liter, use within 2 weeks) DMEM (885 ml), 100 ml of FBS, 10 ml of Pen/Strep and 5 ml of L-Glutamine α-MEM with 10% FBS for preparing MS-5 feeder (1 liter, use within 2 weeks) α-MEM (890 ml), 100 ml of FBS and 10 ml of Pen/Strep Gelatin solution (500 ml) Dissolve 0.5 g of gelatin in 500 ml of warm (50-60 °C) Milli-Q water. Cool to room temperature (15-25 °C) . Matrigel (1 ml aliquots) Thaw the frozen vial of matrigel on ice overnight at 4 °C. Prepare 1 ml aliquots in a 50 ml centrifuge tube using chilled pasture pipettes and freeze at − 20 °C.  crItIcal Matrigel must be thawed slowly to prevent gelatinization. Chilled pasture pipettes and 50 ml centrifuge tubes should be used when making aliquots of the matrigel. CF-1 MEF conditioned media (100 ml per d, use within 1 week) Thaw, rinse and plate two vials of MEFs (around 15 million cells) on a gelatin-coated T225 flask in DMEM with 10% FBS. The next day, aspirate the media, wash the Petri dishes with hESC media to remove residual serum and plate 100 ml of hESC media. After 24 h, collect the MEF conditioned media (CM), and replace with new hESC media. This can be repeated daily for no more than 2 weeks. The media may be stored at 4 °C for less than 1 month. Before using, CM can be sterilized by 0.22 µm filtration and supplemented with 10 ng ml − 1 of FGF2. EQUIPMENT SETUP Gelatin-coated Petri dishes Coat culture Petri dishes or flasks with sterile gelatin solution (0.1% (wt/vol) in water) for about 5 min at room temperature. Aspirate the gelatin solution before plating the cells. Matrigel-coated Petri dishes Dilute a 1 ml frozen aliquot of matrigel in 19 ml of DMEM:F12. A 45 µm cell strainer can be used to remove any insoluble clumps. Coat Petri dishes with the diluted matrigel solution and let them stand for 1 h. Aspirate the matrigel solution and rinse Petri dishes once with DMEM:F12 before plating the cells. PO/Lam/FN-coated plate Coat 15 µg ml − 1 PO in PBS in 60 mm Petri dish and keep it aside for overnight. Next day, wash the PO-coated Petri dish three times with PBS and coat 1 µg ml − 1 laminin and10 µg ml − 1 fibronectin in PBS for a period of at least 2 h (usually overnight). When cells are ready for plating, remove the solution and let the PO/Lam/FN-coat dry for a quick period ( < 5 min) before plating. proceDure Induction of nc cells 1| Maintain hESCs and hiPSCs as described in previous protocols 6, 9, 32, 33 . 2| Induce NC cells either using option A, through MS5 coculture, or option B, using defined system (NSB method) (Fig. 4)  crItIcal step Repeated washing is necessary to dilute out dispase because dispase is not inactivated by serum. Incomplete washing out of dispase prevents hESC colonies from attachment and leads to high levels of cell death. (v) Pipette and triturate the hPSC pellet with 1 ml of hESC medium using P1000 micropipette.
 crItIcal step The number of repeats and the intensity of pipetting determine the size of hPSC colonies. Colonies that remain too large tend to spontaneously differentiate, whereas hPSCs triturated too harshly tend to die on replating. Step (xii)) can be fine-tuned to increase NC yield. In our previous study, we observed that the number of NC (p75 + ) cells is significantly increased on exposure to FGF-2 or BMP4, although addition of extrinsic BMPs does not seem to be essential for NC induction in P1 stage. Antagonists of these pathways can reduce NC induction efficiency 6 . In addition, to influence the quantity of NC induction, different combinations of extrinsic factors also affect lineage predisposition. As observed in various model systems in the mouse and chick embryo, manipulations of the Wnt, BMP, FGF, RA and Shh pathways can greatly impact lineage decisions during NC development 36 . Concentrations of each extrinsic factor need to be individually optimized for each application aimed at biasing lineage choice. Examples of cytokines and compounds controlling efficiency of NC induction in hESCs that have been described previously include 36 Wnt3A (40 ng ml − 1 ), BMP4 (50 ng ml − 1 ), FGF8 (100 ng ml − 1 ), RA (0.5 µM), Shh (200 ng ml − 1 ), SU5402 (10 nM), Dickkopf-1 (100 ng ml − 1 ) and Noggin (500 ng ml − 1 ). ? trouBlesHootInG (xi) At ~12-20 d of differentiation, numerous neural rosette structures emerge from the differentiating hPSCs ( Fig. 5) .
At the latest by day 28 of differentiation, harvest rosette structures mechanically by aspirating colonies using a 1 ml (Fig. 6) . To initiate differentiation, replace the media with KSR medium containing 10 µM SB431542 and 500 ng ml − 1 Noggin. Replace the media and slowly switch from KSR to N2 on days 2, 3, 5, 7, 9 and 11, and as detailed below.  crItIcal step Cell density at the time of initiation of differentiation determines the relative amounts of CNS versus NC cells produced, with lower confluency biasing toward increased numbers of NC cells and high confluency biasing toward CNS lineage. However, at very low confluencies ( < 50% confluent), cell viability diminishes. Initial seeding densities ('plating efficiency') can vary between pluripotent cell lines and should be empirically determined to reach ideal starting conditions. (xiii) On day 2 of differentiation, aspirate the KSR using a sterile glass pipette and add KSR containing 10 µM SB431542 and 500 ng ml − 1 Noggin. (xiv) On day 3 of differentiation, aspirate the KSR using a sterile glass pipette and add KSR containing 10 µM SB431542 and 500 ng ml − 1 Noggin. (xv) On day 5 of differentiation, aspirate the KSR using a sterile glass pipette and add media (75% KSR, 25% N2)
containing 10 µM SB431542 and 500 ng ml − 1 Noggin. (xvi) On day 7 of differentiation, aspirate the KSR using a sterile glass pipette and add media (50% KSR, 50% N2) containing 10 µM SB431542 and 500 ng ml − 1 Noggin. (xvii) On day 9 of differentiation, aspirate the KSR using a sterile glass pipette and add media (25% KSR, 75% N2) containing 10 µM SB431542 and 500 ng ml − 1 Noggin. (xviii) On day 11 of differentiation, aspirate the KSR using a sterile glass pipette and add N2 media containing 10 µM SB431542 and 500 ng ml − 1 Noggin. (xix) NC cells can be observed by day 11 of differentiation based on AP2a, p75 and HNK1 staining (Fig. 7) . Render the cells to single cells using accutase followed by replating and maintenance of the cells in N2 medium or under alterative culture conditions detailed in Step 4. If desired, cells at day 11 may be further purified for NC lineage using flow cytometric sorting for p75 and HNK1, as described below.
Isolation of hpsc-derived nc cells using antibody-mediated flow cytometry sorting 3| On the day 6 or 7 in P1 culture in the MS5 protocol (see Step 2A), change medium with accutase (or HBSS) for 20-30 min and harvest the P1 culture with cell scraper.  crItIcal step Note that we describe this step in detail for cells generated using the MS5 protocol (Step 2A). However, the same strategy can be adapted for cells generated using the NSB protocol (Step 2B).  crItIcal step To determine the presence of NC populations at P1, parallel cultures can be pre-screened by immunocytochemistry. Neuroectodermal marker (Pax6)-positive cells should be interspersed with NC marker (AP2)-positive cells (Figs. 5f and 7) . If the goal is to prepare a NC-depleted population, it is possible to manually harvest rosette structures and remove any surrounding cells using a fine needle (27-30 G) attached to 1 ml syringe.
4|
Centrifuge the harvested cells from P1 culture stage for 5 min at 160g at room temperature and aspirate the supernatant. Mechanically triturate cells in PBS containing 2% serum (FBS).
5|
Label triturated P1 cells (10 million cells per ml) with antibodies (p75, 5-10 µl ml − 1 ; HNK1, 10-20 µl ml − 1
) for flow cytometry for 20 min on ice in the dark. Centrifuge for 5 min at 160g at room temperature and aspirate the supernatant.  crItIcal step The concentration of each lot of antibody may need to be optimized. FACS analysis with appropriate controls is essential to identify optimal antibody dilutions.
6|
Resuspend cells in PBS containing 2% serum (FBS) and label it with appropriate fluorochrome-labelled secondary antibody (1:1000 to 1:500 dilution) for each primary antibody.
7|
Perform cell sorting by flow cytometry. Collect p75 + and HNK1 + cells (double-positive cells) for further culture (Fig. 8) .  crItIcal step It is essential to have controls of hESC-derived NC cells that are unstained and stained with appropriate secondary antibodies only for defining sorting gates in the FACS machine. As most cells under these conditions are either double positive (p75 + and HNK1 + ) or double negative, it may be possible to use sorting for single markers (HNK1 or p75) without a major loss of specificity. However, using single markers outside the narrow differentiation window (P1 stage) may result in contamination with other cell types such as CNS neuroblast, cells of placode origin or early mesodermal cells. Dead cells can be excluded for cell sorting by using 7-AAD or DAPI. ? trouBlesHootInG
8|
Collect double-positive cells in PBS containing 2% serum.
9|
Centrifuge the sorted cells for 5 min at 160g at room temperature and aspirate the supernatant.
propagation of isolated hpsc-derived nc cells 10| Propagate isolated hPSC-derived NC cells using option A with attached culture or option B using sphere formation.
Figure 7 | NC cell marker expression using NSB induction. By day 11 in cultures, the NC markers AP2, p75 and HNK1 (all red) can all be found expressed in the non-PAX6 (green)-expressing cells. (Fig. 9, left panel) .  crItIcal step Minimum plating number is 50,000-100,000 cells per cm 2 to ensure survival of sorted cells. Viability of sorted cells is high when special precautions are taken to minimize pipetting and other mechanical stress.  crItIcal step Supplementing the medium with serum or chick embryo extract (as commonly used in primary NC cultures) did not enhance the survival or proliferation of hESC-NC cell cultures under these conditions. For preparing pre-conditioned medium, collect medium from P1 culture (Step 16) and sterilize by 0.22 µm filtration. The pre-conditioned medium can be used by mixing at ratios of 1:1 to 1:6 with fresh N2 medium to further enhance survival of sorted cells after plating. ? trouBlesHootInG (ii) Culture the hPSC-NC cells with N2 medium supplemented with 10 ng ml − 1 of FGF2 and 10 ng ml − 1 of EGF. Change the media every 2-3 d and passage every 7-8 d. Accutase or HBSS treatment can be used for dissociation of NC cells for splitting.
(B) culturing of sorted nc cells in sphere formation
(i) Resuspend the pellet by tapping the tube (not pipetting) and plate on ultra-low attachment six-well plate in 1,000-10,000 cells per cm 2 with 2 ml of N2 medium supplemented with 10 ng ml − 1 of FGF2 and 10 ng ml − 1 of EGF. The sphere is typically observed by 24 h after plating (Fig. 9, right panel) .
(ii) After every 7 d of culture, dissociate spheres with accutase treatment for 20 min. Filter triturated cells using a 40 µm cell strainer and obtain NC cells. After cell counting using hemocytometer, plate at 1,000-10,000 cells per cm 2 into new ultra-low attachment plates in N2 medium supplemented with 10 ng ml − 1 of FGF2 and 10 ng ml − 1 of EGF. ) and cyclic AMP (0.5 mM) for 2 weeks. Change the medium including growth factors every 3-4 d (Fig. 10) . For improving selective subtype specification toward either sensory or autonomic neuron fate, optimizing growth factor composition, in particular Wnt and BMP signaling factors, is of further consideration.
Differentiation of hpsc-derived nc cells
(B) schwann cells specification with hpsc-derived nc cells
(i) After flow cytometric purification at the end of P1 stage (Step 3), culture hESC-NC cells in N2 supplemented with 10 ng ml − 1 of FGF2 and 10 ng ml − 1 of EGF for more than 30 d (Step 4). Depending on the hPSC line used, the optimal time period to maintain cells under FGF2/EGF conditions (Step 4) can vary. The average period is ~60 d. After FGF2/EGF culture, differentiate the 'aged' hESC-NC cells along the Schwann cell lineage in N2 medium supplemented with ciliary neurotrophic factor (10 ng ml − 1 ), neuregulin (20 ng ml − 1 ), FGF2 (10 ng ml − 1 ) and cyclic AMP (0.5 mM) for 3 weeks (Fig. 11) .  crItIcal step As shown in our previous report, Schwann cell differentiation is not observed during early (Fig. 12) . These cells express a series of cell surface marker such as CD73, Stro-1 and CD146, typically associated with mesenchymal stem cell identity 37 . Indeed, our previous study showed that cells expressing myofibroblast markers in hPSC-NC cultures can readily give rise to adipocytes, chondrocytes, osteocytes and smooth muscle cells, as shown previously for primary cranial NC precursors (Fig. 13 ) 35, 38, 39 .
(ii) For adipogenic differentiation, grow hESC-NC-MPCs to confluence, followed by exposure to 1 mM dexamethasone, 10 µg ml − 1 Insulin and 0.5 mM IBMX in α-MEM medium containing 10% FBS for > 3 weeks. (iii) For chondrogenic differentiation, pellet hESC-NC-MPCs for 5 min at 160g at room temperature and take out supernatant without disruption of pellet structure. Then pellet culture can be performed with 10 ng ml − 1 TGFβ-3 and 200 µM AA in α-MEM medium containing 10% FBS for > 4 weeks. (iv) For osteogenic differentiation, plate hESC-NC-MPCs at low density (1 × 10 3 cells per cm 2 ) on tissue culture-treated Petri dishes in the presence of 10 mM β-glycerol phosphate, 0.1 µM dexamethasone and 200 µM AA in α-MEM medium containing 10% FBS for 3-4 weeks.
• tIMInG The NC cell differentiation takes ~30 d using the MS5 coculture approach ? trouBlesHootInG Troubleshooting advice can be found in table 1. antIcIpateD results This protocol should reliably yield enriched populations of hPSC-NC cells after cell sorting. Final yield depends on the specific hPSC line used, the efficiency of rosette formation and the specific cytokines added during P1 culture (Fig. 5) . The protocol allows purification of hPSC-NC cells without the need for genetic manipulation or drug selection using a simple antibodymediated cell sorting strategy (Fig. 8) . Approximately 30% (32.4% ± 5%) of total cells can be considered NC precursors based on coexpression of p75 and HNK1 at day 7 of P1 culture (MS5 protocol). Approximately 15-40% of total cells coexpress p75/HNK1 at day 12 of the NSB protocol. Flow cytometric analysis of purified NC precursors should show coexpression with CD29 (97.1% ± 2.5%); CD133 (65.3% ± 15%); CD49d (75.3% ± 5%); CD49b (67.4% ± 19%); and CXCR4 (67.1% ± 12%). When plated at clonal density, approximately half of the single cell-derived NC precursor cultures should yield multipotent differentiation (Tuj1 + neuronal cells, GFAP + Schwann cells and SMA + myofibroblast). We have previously shown that unbiased microarray gene expression analysis identifies the majority of highly enriched transcripts as established NC precursors markers such as AP2b, Sox10 and Erbb3. Accordingly, more than 90% of the purified NC precursors should coexpress Sox10 and Ap2. The yield of p75 + /HNK1 + precursors (15-40%) using the NSB protocol is comparable with the yield using the MS5 protocol. However, the efficiency of generating specific NC sublineages using the NSB protocol remains to be determined. At the current stage, it is also unclear whether there are distinct properties of NC precursors derived through the NSB versus MS5 protocol, such as a possible bias toward pre-versus post-migratory or NC populations (Figs. 2 and 3) . Another powerful technique to identify and purify neural cell lineages derived from hPSCs includes the use of stable transgenic reporter lines. We have recently established the use of bacterial artifical chromosome (BAC)-based transgenic reporters in hESCs 40 . BAC transgenic reporter hESC lines can be used in a complementary manner with the protocols presented here such as for the purification of peripheral neurons derived from p75 + /HNK1 + hESC-NC precursors cells (e.g., using the recently published Dll1::eGFP line 40 , marking neuronal committed cells after hESC-NC precursor cell isolation or the isolation and propagation of putative hESC-derived NC stem cells using the recently established Sox10::eGFP hESC line (unpublished data)). A brief outline for generating stable BAC transgenic reporter lines is provided including retrofitting of the BAC construct for mammalian selection (Box 1) and the specific conditions for introducing the BAC construct into hESC lines and selecting for stable BAC transgenic reporter lines (Box 2). In addition to the isolation of NC precursor cells, we also present conditions that allow hESC-NC cell proliferation and further differentiation toward peripheral neuron fates (Fig. 10) , Schwann cells (Fig. 11) and myofibroblasts (Fig. 12) . During peripheral neuronal differentiation, we could observe 40-60% of Tuj1 + /peripherin + cells from total cell populations. During It is important to note that MEFs from different manufacturers (and to some extent from different lots) adhere to the Petri dish with different efficiencies. We always coat the tissue culture plastic with 0.1% gelatin and keep it for at least 15 min before plating. Dispase (neutral protease) (Worthington Bioscience): Prepare dispase based on its activity (6 U ml − 1 ) and make up the solution using hESC media. Filter sterilize before use. Matrigel and matrigel-coated petri dishes (BD Bioscience): We only use Matrigel with high protein content, 10 mg ml − 1 or higher. To coat a Petri dish, add 1 ml Matrigel to 19 ml of DMEM:F12. Pipette the mixture a few times to mix before placing in culture Petri dish. Leave the Petri dish in the hood for 1 h at room temperature. Before using, aspirate the Matrigel off the surface and plate cells directly onto the coated Petri dish without a wash. preparation of hescs 1. Expand hESCs on MEFs until they are ready to passage (~7 d). 2. Passage hESCs after digestion using 6 U ml − 1 dispase for ~7 to 9 min at 37 °C tissue culture incubator. Use 10 ml dispase per 15 cm Petri dish. 3. Carefully detach colonies from MEFs by lightly pipetting dispase over the surface of the Petri dish. 4. Split 10 ml dispase/hESCs into two 15 ml conical tubes, 5 ml in each. 5. Gently add 10 ml hESC media to each conical tube, making up the total volume to 15 ml in each tube. 6. Centrifuge at 200g for 5 min at room temperature. 7. Carefully aspirate the supernatant. 8. Add 10 ml hESC media and gently break up the pellet.  crItIcal step Do not break up the colonies. Excessive trituration reduces viability, hence pipette up and down gently 2-3 times. 9. Centrifuge at 200g for 5 min at room temperature. 10. Carefully aspirate the supernatant. 11. Carefully resuspend the pellet into MEF CM and replate hESCs in the ratio of 1:1 to 1:2 onto Matrigel-coated Petri dishes.  crItIcal step Residual dispase can cause poor adhesion to the Matrigel. Perform a third wash if adhesion is a problem. 12. Expand hESCs on Matrigel from 3 to 5 d, feeding with fresh MEF-conditioned hESC media containing 10 ng ml − 1 FGF2 daily. nucleofection 13. The day before nucleofection, plate a 15 cm Petri dish of Neomycin-resistant MEFs for each nucleofection sample. 14. On the morning of nucleofection, prepare MEFs by aspirating the plating media, washing once with PBS and adding hESC media containing 10 µM Y-27632. Place it in tissue culture incubator (37 °C). 40 . Resuspend the final cell pellet in 50 µl ice-cold water and add 100 ng of pRetroNeo to one induced and one uninduced sample. 41. Transfer DNA/E.coli to an ice-cold 0.1 cm electroporation cuvette. 42. Electroporate using 1.75 kV, 25 µF with the pulse controller set at 200 Ω. 43. Add 1 ml of LB to the electroporated cuvette and transfer its contents to a round-bottomed snap-cap tube, leaving the lid loose for aeration. 44. Shake at 225 r.p.m. for 1 h at 30-32 °C. 45. Plate onto LB agar with 12.5-20 µg ml − 1 chloramphenicol and 50 µg ml − 1 spectinomycin. 46. Incubate plates overnight (possibly two nights) at 30-32 °C. 47. Pick isolated colonies, make glycerol stocks and perform restriction enzyme digests to verify BAC structure. 48. Correct BAC clones should be moved into DH10B E.coli to ensure that there is no leaky Cre expression. Follow the first protocol for synthesizing BAC DNA, and either make DH10B electrocompetent as above or purchase it from Invitrogen (e.g., cat. no. 6400-03).
Box 1 | CoNTINUED
(continued) 
